Robert Allen
Chief Tech/Sci/R&D Officer presso INVIVYD, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Robert D.
Allen is currently the Chief Scientific Officer at Invivyd, Inc. He previously worked as the Scientific Director at Oregon Translational Research & Development Institute and as the Senior Vice President-Research & Development at Sorrento Therapeutics, Inc. From 2020 to 2023, he served as the Chief Scientific Officer at SmartPharm Therapeutics, Inc. Dr. Allen holds a doctorate degree from The Trustees of Columbia University in The City of New York, a graduate degree from Georgia Institute of Technology, and an undergraduate degree from Rhodes College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
INVIVYD, INC.
-.--% | 22/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Robert Allen
| Società | Posizione | Inizio |
|---|---|---|
| INVIVYD, INC. | Chief Tech/Sci/R&D Officer | 12/04/2023 |
Precedenti posizioni note di Robert Allen
| Società | Posizione | Fine |
|---|---|---|
SmartPharm Therapeutics, Inc.
 SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/01/2023 |
| Oregon Translational Research & Development Institute | Chief Tech/Sci/R&D Officer | - |
| SORRENTO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Formazione di Robert Allen
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Georgia Institute of Technology | Graduate Degree |
| Rhodes College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
| Oregon Translational Research & Development Institute | |
SmartPharm Therapeutics, Inc.
SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Robert Allen
